Resmetirom for MASH: A Comprehensive Review of a Novel Therapeutic Frontier
Sign Up to like & getrecommendations! Published in 2025 at "Biomedicines"
DOI: 10.3390/biomedicines13092079
Abstract: Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease linked to type 2 diabetes (T2D), obesity, and dyslipidaemia, which are all parts of the metabolic syndrome. In 2024, for non-cirrhotic MASH with mild to advanced… read more here.
Keywords: comprehensive review; review novel; mash comprehensive; mash ... See more keywords